In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

10x Genomics gets $50mm in Series D funds, secures $75mm in debt facility

Executive Summary

10x Genomics Inc. (genomic discovery) raised $50mm in a Series D financing led by Meritech Capital Partners, which was joined by first-time backer Wells Fargo Strategic Capital and returning shareholders Paladin Capital, Fidelity, and the SoftBank Group. The company also secured a $75mm credit facility with Silicon Valley Bank. 10x will use the proceeds for ongoing product development, global commercialization activities, and expansion of its internal manufacturing operations.

Deal Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Venture Financing

Related Companies